Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD

E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland)

Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Session: COPD: novel pathological mechanisms in the airway epithelium
Session type: Thematic Poster
Number: 4271
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland). Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD. 4271

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: